Clinical trial
Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Bladder Overactivity
NCT00475696 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Bladder Overactivity
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2002
- Completion date
- March 31, 2005
- Enrollment
- 300
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.